| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/07/2005 | US20050075280 Novel antiarrythmic peptides |
| 04/07/2005 | US20050075279 Macrocyclic peptides active against the hepatitis C virus |
| 04/07/2005 | US20050075278 Compositions of sunflower trypsin inhibitors |
| 04/07/2005 | US20050075277 Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects |
| 04/07/2005 | US20050075275 Regulation of the apj receptor for use in the treatment or prophylaxis of cardiac diseases |
| 04/07/2005 | US20050075268 cell is contacted with a photosentistising agent, cell is irradiated with light to activate photosentisitising agent, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination |
| 04/07/2005 | US20050075102 Personal-call and feature control system and method for controlling telephones, providing extended features for such telephones and routing of media-rich calls |
| 04/07/2005 | US20050074884 Identification of peptides that facilitate uptake and cytoplasmic and /or nuclear transport of proteins, DNA and viruses |
| 04/07/2005 | US20050074882 Using immunoglobulin specific to human leukocyte antigen receptor to modify mitochondrial metabolism and kill tumor cells; immunotherapy; antitumor agents |
| 04/07/2005 | US20050074879 Antisense oligonucleotide modulation of STAT3 expression |
| 04/07/2005 | US20050074875 Methods of tissue repair and regeneration and tissue engineered compositions |
| 04/07/2005 | US20050074866 Mixture comprising antihemophilic and/or von willebrand factors, antithrombin and sodium heparin for use as tool in treatment of blood disorders |
| 04/07/2005 | US20050074864 Expression vector comprising nucleotide sequences coding carybdea blood lysis protein for use as tool in treatment and prevetion of platelet agglutination disorders; pesticides |
| 04/07/2005 | US20050074863 Chemoprotective agent comprising lymphocyte epitopes for use in treatment of cell proliferative disorders |
| 04/07/2005 | US20050074853 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells |
| 04/07/2005 | US20050074852 Serine/threonine kinase (PKN) peptides for use in identifying modulators for treatment and prevention of inflammation, cancer, arteriosclerosis and psoriasis |
| 04/07/2005 | US20050074849 Peptides |
| 04/07/2005 | US20050074845 Use of Saccharomyces cerevisiae Erg4 mutants for expressing mammalian glucose transporters |
| 04/07/2005 | US20050074842 Membrane protein for use as tools in generation of vaccine; medical diagnosic and drug screening tools |
| 04/07/2005 | US20050074838 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 04/07/2005 | US20050074837 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/07/2005 | US20050074836 Containing modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII |
| 04/07/2005 | US20050074830 Screening method for an agent having an affect on a sphingosine kinase signaling pathway |
| 04/07/2005 | US20050074825 Using cell cycle protein (TANKYRASE H) as screening tool to identify modulators for treatment and prevention of cell proliferative disorders; antisense agents; gene expression inhibition |
| 04/07/2005 | US20050074818 Methods and agents for the diagnosis and therapy of chronically inflammatory intestinal diseases |
| 04/07/2005 | US20050074813 Model for testing immunogenicity of peptides |
| 04/07/2005 | US20050074812 Molecules that home to various selected organs or tissues |
| 04/07/2005 | US20050074808 Transmembrane receptor (CON 167) for use as tool in detecting modulators for treatment and prevention of nervous system disorders |
| 04/07/2005 | US20050074807 Heterogeneous nuclear ribonucleoprotein overexpression for use as diagnostic/prognostic tool in detection of cell proliferative disorders |
| 04/07/2005 | US20050074805 Specific markers for diabetes |
| 04/07/2005 | US20050074798 Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancer |
| 04/07/2005 | US20050074797 FHIT proteins and nucleic acids and methods based thereon |
| 04/07/2005 | US20050074777 Novel cell-surface estrogen receptor and related compositions and methods |
| 04/07/2005 | US20050074767 Using transcriptional activity of obesity genes as diagnostic indicator of efficacy of dietetic modulators; treating eating/weight disorders |
| 04/07/2005 | US20050074764 Using presence of point mutations in nicotinic acetylcholine receptor (nACHR) gene as diagnostic/prognosic tool in detction and treatment of indicator of cardiovascular, nervous system, vision and pain disorders |
| 04/07/2005 | US20050074763 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 04/07/2005 | US20050074761 Novel means for the diagnosis and therapy of ctcl |
| 04/07/2005 | US20050074758 Prokineticin polypeptides, related compositions and methods |
| 04/07/2005 | US20050074757 Compositions and methods for inhibiting expression of a mutant gene |
| 04/07/2005 | US20050074756 FALP proteins |
| 04/07/2005 | US20050074755 Nucleotide sequences coding mutator locus gene for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 04/07/2005 | US20050074754 Membrane protein for use in diagnosis, treatment and prevention of inflammation; immunosuppressants |
| 04/07/2005 | US20050074751 Binding viral protein during latency life cycle; binding of antibodies to excellular segments of protein; immobilization; removal of infecting cells; autoimmune disease, lupus, antiarthritic agents |
| 04/07/2005 | US20050074749 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 04/07/2005 | US20050074748 Bioreactive agents |
| 04/07/2005 | US20050074747 Identifying peptide sequences that selectively bind to preferential bio-targets for use in diagnosis of viral disease, diabetes, inflammatory, arthritic, atherosclerotic, cell proliferative, autoimmune and cardiovascular disorders |
| 04/07/2005 | US20050074497 Sustained release delivery systems; contact lens shape; includes vision correction; lower dosage antiangiogenesis therapeutics; reduced local inflammation and/or adverse systemic reactions; macular degeneration; retinopathies |
| 04/07/2005 | US20050074492 Sustained release ionic conjugate |
| 04/07/2005 | US20050074485 Anti-inflammatory/anti-microbial peptides for use in dialysis |
| 04/07/2005 | US20050074481 Device for regeneration of articular cartilage and other tissue |
| 04/07/2005 | US20050074468 Topical compositions containing nonimmunosuppressive cyclosporin derivatives for treating hair loss |
| 04/07/2005 | US20050074466 Botulinum toxin in the treatment or prevention of acne |
| 04/07/2005 | US20050074463 Therapeutic vaccination method, mutated peptides of hiv reverse transciptase and their use for vaccination and diagnostic purposes |
| 04/07/2005 | US20050074462 Suppressing IgE immunoglobulin mediated hypersensitivity; transdermal administration |
| 04/07/2005 | US20050074461 Transdermal botulinum toxin compositions |
| 04/07/2005 | US20050074460 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide |
| 04/07/2005 | US20050074459 Escherichia coli O157:H7 epithelial adhesin |
| 04/07/2005 | US20050074454 Methods of treating carcinoma using anti-TNF antibodies and peptides |
| 04/07/2005 | US20050074453 Preventing scar formation; introducing human recombinant phage antibody into area following operation |
| 04/07/2005 | US20050074451 Synergistic combination of methotrexate with antibody to alpha 4 integrin or immunologically active antigen binding fragment |
| 04/07/2005 | US20050074448 Method of treatment of endothelial dysfunction and engineered proteins for same |
| 04/07/2005 | US20050074447 Treatment for diabetic microvascular and macrovascular complications |
| 04/07/2005 | US20050074443 Fatty alcohol combined with vitamin B12, vitamin D, coenzyme Q and/or omega-3 fatty acid; decreasing tissue destructive inflammation; nontoxic |
| 04/07/2005 | US20050074439 Utilized for expression of desired heterologous DNAs |
| 04/07/2005 | US20050074438 Peptidyl prolyl cis trans isomerase activity; antioxidants; preventing transplant rejection; myoblast cell line |
| 04/07/2005 | US20050074436 Systems and methods for treating patients with processed lipoaspirate cells |
| 04/07/2005 | US20050074434 Remedies for metabolic bone diseases |
| 04/07/2005 | US20050074429 Optimal compositions and methods thereof for treating HCV infections |
| 04/07/2005 | US20050074428 Adjuvant agent for hepatitis C |
| 04/07/2005 | US20050074427 IL-17 like molecules and uses thereof |
| 04/07/2005 | US20050074426 A conjugate of a cytokine and a tumor targeting moiety with numerous provisos |
| 04/07/2005 | US20050074423 subtilisin, pepsin or trypsin used for the protein hydrolysis of ground oyster flesh; liquid form; freeze dried powder form |
| 04/07/2005 | US20050074416 lactic bacteria strain dairy in origin, may administer in an edible composition, adheres to tooth surface and produces growth inhibition factor |
| 04/07/2005 | US20050072736 Purification process |
| 04/07/2005 | US20050072372 Hair removal and animal husbandry method |
| 04/07/2005 | DE10340747A1 Use of a 11-beta-hydroxysteroid oxidoreductase inhibitor or cortisol synthesis activator to prepare a topical pharmaceutical or cosmetic composition for stimulating breast growth |
| 04/07/2005 | CA2540706A1 Royal jelly peptide and composition containing the same |
| 04/07/2005 | CA2540644A1 A method of modulating cell survival, differentiation and/or synaptic plasticity |
| 04/07/2005 | CA2540283A1 Tumor vaccine |
| 04/07/2005 | CA2540160A1 Novel triterpene derivatives, preparation thereof and use thereof |
| 04/07/2005 | CA2540108A1 Antitumor agent_comprising a histone deacetylase inhibitor and a topoisomerase ii inhibitor |
| 04/07/2005 | CA2540031A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 04/07/2005 | CA2540006A1 Treating inflammation using a biological agent that causes cells to release cytokine receptors |
| 04/07/2005 | CA2539947A1 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage |
| 04/07/2005 | CA2539918A1 Vege-cor vege-d materials and methods for stimulation of neural stem cells |
| 04/07/2005 | CA2539914A1 Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| 04/07/2005 | CA2539895A1 Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-n-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compo |
| 04/07/2005 | CA2539823A1 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | CA2539752A1 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 04/07/2005 | CA2539694A1 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading |
| 04/07/2005 | CA2539596A1 Melanocortin receptor agonists |
| 04/07/2005 | CA2539486A1 Methods for preparing oil bodies comprising active ingredients |
| 04/07/2005 | CA2539472A1 Ocular solutions containing a macrolide antibiotic and/or mycophenolic acid |
| 04/07/2005 | CA2539445A1 Agent for promoting osteogenesis and/or inhibiting bone resorption |
| 04/07/2005 | CA2539238A1 Altering animal waste composition |
| 04/07/2005 | CA2538680A1 Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation |
| 04/07/2005 | CA2538083A1 Methods of treating autoimmune diseases using il-21 |
| 04/07/2005 | CA2538023A1 Therapeutic regimens for administering drug combinations |
| 04/07/2005 | CA2537335A1 Use of antisecretory factor for neuroprotection |
| 04/06/2005 | EP1520860A2 Recombinant protein PilC, method for its production and use thereof |